EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC 4.0

High-Sensitivity Cardiac Troponin I and Mortality Following Off-Pump and On-Pump Coronary Artery Bypass Surgery: A Secondary Analysis of the Vision Cardiac Surgery Study

Grace S Lee iD, Derrick Y Tam, Dominique Vervoort iD, Shun Fu Lee, Katheryn Brady, Emilie Belley-Cote, P J Devereaux, Andre Lamy iD, Richard Whitlock, Ryan Louie, Stephen E Fremes iD

Interdisciplinary CardioVascular and Thoracic Surgery · 2026

DOI: 10.1093/icvts/ivag033 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, 2026. Verfasst von Grace S Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, University of Toronto, Toronto, ON M5G 2C4, Canada. Hauptthemen laut MEDLINE: Coronary Artery Bypass, Coronary Artery Bypass, Off-Pump, Coronary Artery Disease, Troponin I. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The VISION Cardiac Surgery Study, Canadian Institute of Health Research (CIHR), CIHR Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We aimed to determine whether high-sensitivity cardiac troponin I (hs-cTnI) thresholds associated with increased 30-day mortality isolated coronary artery bypass grafting (CABG) differed between those undergoing off-pump (OPCAB) and on-pump (ONCAB) CABG.

Methods

We conducted a subanalysis of patients who underwent isolated CABG in the Vascular Events in Surgery Patients Cohort Evaluation (VISION) Cardiac Surgery Study. Cox regression was used to determine the hazard ratios (HRs) for mortality based on postoperative day 1 log-transformed hs-cTnI adjusted by EuroSCORE II, with OPCAB versus ONCAB as an interaction term. HRs were modelled as a function of hs-cTnI, and the lowest troponin associated with HR ≥ 1.00 was identified for each group.

Results

Of the original VISION cohort, 6505 patients underwent isolated CABG (OPCAB = 1141, ONCAB = 5364). Median hs-cTnI after CABG was 2446 ng/L (interquartile range [IQR] 1164-5654), and lower after OPCAB (640 ng/L [264-1689]) than ONCAB (2972 ng/L [1536-6448], P < .001). There were no differences in 30-day mortality between OPCAB and ONCAB (1.7% vs 1.4%, P = .5). Increased log-peak hs-cTnI was associated with greater mortality after CABG (adjusted HR = 1.7 [95% CI, 1.4-2.1]). The hs-cTnI threshold associated with HR ≥ 1.00 for isolated CABG was 6549 ng/L (95% CI, 3609-8381). OPCAB versus ONCAB had a significant interaction effect on the association between hs-cTnI and mortality (interaction P = .002). The hs-cTnI threshold associated with mortality after OPCAB was ≥4708 ng/L (95% CI, 581-7177), compared to ≥6806 ng/L (95% CI, 4001-13 993) after ONCAB.

Conclusions

The clinically significant hs-cTnI threshold after CABG associated with an increased risk of 30-day mortality above the baseline is substantially higher than defined by current guidelines, but lower in patients undergoing OPCAB compared to ONCAB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery BypassCoronary Artery Bypass, Off-PumpCoronary Artery DiseaseTroponin IAgedFemaleHumansMaleMiddle AgedBiomarkersRisk AssessmentRisk FactorsTime FactorsTreatment Outcome

Stichwörter der Autor:innen

CABGmyocardial infarctionoff-pump CABGon-pump CABGtroponin

Substanzen

BiomarkersTroponin I

Autor:innen und Institutionen

  • Division of Cardiac Surgery, University of Toronto, Toronto, ON M5G 2C4, Canada.
  • Schulich Heart Program, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.
  • Institute of Health Policy, Management and Evaluation, Toronto, ON M5T 3M6, Canada.
  • Population Health Research Institute, Hamilton, ON L8L 2X2, Canada.
  • Health Research Methods, Evidence, and Impact, Hamilton, McMaster University, ON L8S 4L8, Canada.
  • Division of Cardiology, McMaster University, Hamilton, ON L8S 4L8, Canada.

ORCID-Profile: Grace S Lee, Dominique Vervoort, Andre Lamy, Stephen E Fremes

Förderung

  • The VISION Cardiac Surgery Study
  • Canadian Institute of Health Research (CIHR)
  • CIHR Foundation
  • CIHR Strategy for Patient Oriented Research
  • Abbott Laboratories
  • Hamilton Health Sciences New Investigator Fund and Research Strategic Initiative
  • Canadian Network and Centre for Trials Internationally
  • McMaster University Surgical Associates

Zitieren

APA

Lee, G. S., Tam, D. Y., Vervoort, D., Lee, S. F., Brady, K., Belley-Cote, E., Devereaux, P. J., Lamy, A., Whitlock, R., Louie, R., & Fremes, S. E. (2026). High-Sensitivity Cardiac Troponin I and Mortality Following Off-Pump and On-Pump Coronary Artery Bypass Surgery: A Secondary Analysis of the Vision Cardiac Surgery Study. Interdisciplinary CardioVascular and Thoracic Surgery. https://doi.org/10.1093/icvts/ivag033

Vancouver

Lee GS, Tam DY, Vervoort D, Lee SF, Brady K, Belley-Cote E, et al. High-Sensitivity Cardiac Troponin I and Mortality Following Off-Pump and On-Pump Coronary Artery Bypass Surgery: A Secondary Analysis of the Vision Cardiac Surgery Study. Interdisciplinary CardioVascular and Thoracic Surgery. 2026. doi:10.1093/icvts/ivag033

BibTeX
@article{Lee2026,
  author = {Lee, Grace S and Tam, Derrick Y and Vervoort, Dominique and Lee, Shun Fu and Brady, Katheryn and Belley-Cote, Emilie and Devereaux, P J and Lamy, Andre and Whitlock, Richard and Louie, Ryan and Fremes, Stephen E},
  title = {High-Sensitivity Cardiac Troponin I and Mortality Following Off-Pump and On-Pump Coronary Artery Bypass Surgery: A Secondary Analysis of the Vision Cardiac Surgery Study},
  journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
  year = {2026},
  doi = {10.1093/icvts/ivag033}
}
Kostenlos starten →